A 60-year old Danish woman who died of a blood clot after receiving AstraZeneca’s COVID-19 vaccine had “highly unusual” symptoms, the Danish Medicines Agency said late on Sunday.
It said the woman had a low number of blood platelets and clots in small and large vessels, as well as bleeding.
European vaccination programs have been upset in the last two weeks by reports that recipients of the AstraZeneca inoculation have suffered blood clots.
The European Medicines Agency has said there is no indication that the events were caused by the vaccination, a view that was echoed by the World Health Organization on Friday.
AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.
Thailand to start using AstraZeneca vaccine after delay over blood clot fearsThailand will start using the AstraZeneca COVID-19 vaccine on Tuesday after a brief delay due to concerns over its safety, officials said, with the ... Coronavirus
More countries stop using AstraZeneca COVID-19 vaccine amid growing fearsAstraZeneca Plc’s vaccine for COVID-19, once expected to be a mainstay of protection for much of the world, remains shrouded in controversy as more ... Coronavirus
Netherlands halts use of AstraZeneca COVID-19 vaccine amid fears of side effectsThe Netherlands on Sunday joined a fast-growing list of countries suspending use of AstraZeneca’s COVID-19 vaccine after reports of unexpected ... Coronavirus
Ireland temporarily suspends AstraZeneca COVID-19 vaccineIreland became the latest country to stop using AstraZeneca’s COVID-19 vaccine on Sunday, temporarily suspending the shot “out of an abundance of ... Coronavirus